# Moderna shares soar 60% on melanoma vaccine trial success

> **Open Intelligence Dossier** · First detected: 2026-08-19 13:07 UTC · Category: Business

## Executive Summary
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Moderna shares soar 60% on melanoma vaccine trial success&quot; is generating significant coverage in the Business category, with 3 articles from 3 distinct sources tracked by PULSE so far.


Outlets currently covering the story include MarketWatch, CNN and Financial Times. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Forbes | Why Is Moderna Stock Down Today? | [Source Link](https://news.google.com/rss/articles/CBMi2AFBVV95cUxNY096N2NVMzNOcFFhd2pZZjV1bHJmdFVTS3dpcDFQWVlnMHhSbWdQRklFX29hX3ZuWFZfT1VCa3J3OGZrRUR5bEJITmlpR20xaG4tcnVYVjdSVC1fX0VfM1Vja0VhUFFtOGZSQmZqNHg2amhlUjIzU2M3d1Nxc09uOVZlYnd1VXJaQXdqbGxOWk9ldlhrOFVZQmJVY3R2a2pHTS01aktaX2F6dUd0VEl6Q3JiWjFMc0xqZU5nRThwNUkzUlpVR0ZJZ2hoOVBrdWI1OGxMWUZOcFg?oc=5) |
| Yahoo Finance | Why Did MRNA, MRK, TGT Stocks Jump To 52-Week Highs Today? | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxNcHhIR0YzSUNxak1wS2JsOURjdDNPNFJnUzZDU3FpOFVnUDRmQjZLNDZ4bDVGczE5c29ud2dNaVMwNGdkbklORGZkZmhGZmVkdE9FVE9QMFZhdFlTbFQ3dUFLOW9PNWxDQ2hJSXFrMHRvSVV0bzd5Y1Z3UVEzNzBFUnJGZzIyVXBRWWxHZmR3?oc=5) |
| Yahoo Finance | Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxQTndyNlZmUFhXVnZsZWxlWVo4MU50MjZRbVdyOGt4Y1lIYUJ4VVZmQVNjbmtHU2Q0UkszZlhMV0J1a1NkczNyQmx4X2E5eE4yNWpwV0E2cUVyRmRtUnQ3cWRRblljQVdHUDM0MU42THRub09ib0tXbjJWRXdSNEd5VXRGaVNkWXhQQklDTlpB?oc=5) |
| MarketWatch | Moderna’s stock doubles on promising cancer-vaccine results | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxOWE1Udkk0ZjRFQVFqRTFtRUNIeTlKcGtpdDh1TkduS2Q5bk1BMzJoNnExX2lrbktQeXM0X1JFQWxxUnp1aGh4MFhhMjB3R2lWMUJPczB6Tk00TklSV1pmczhnNFU2UUZ3NEVEZ1hudjFaclNRR1Q5YzIyZ29kQkpETkw1cTJaaWEtd2g5bXBBSGZidEJmSzNteXZudXozWklLTmY0?oc=5) |
| CNN | Moderna shares surge as melanoma vaccine with Merck succeeds in large trial | [Source Link](https://news.google.com/rss/articles/CBMifkFVX3lxTE5rdk1JZHNYak56OXBuQ1JlcjdfM3FOdTJEUEJ1UXJ5Ri1yOGxjNWQwZWF0VGw0emZ6dFlsS2VYc1lYTkl3QjBQeWVvOWpOcE1MazVPY1NBZjgtR0tQZndfS1BCQjhvUEM5MWZaV0dKb3AtQi11S1NEZXJRcXo3QQ?oc=5) |
| Financial Times | Moderna shares soar 60% on melanoma vaccine trial success | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxNbWJYYzNKOEdmU29RTmRkM0ZOTEF1eEFVZW9BVUEwVWt6N3hKd2xNSFc0eGdRdmN2ZzJOOHA3ZFJrY0JoSzhKb2FIU01QTHdwM20xV2V4dXVGWGxDTndUbU43OUZwUTByX3pRQXlxWmVQcTZxcUVFdmc0dDJfYTVWb0ZtOG0?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-19/moderna-shares-soar-60-on-melanoma-vaccine-trial-success*
